According to the research report titled ‘Global Sepsis Diagnostics Market 2021-2028’, available with Market Study Report, global sepsis diagnostics market is projected to register a y-o-y growth rate of 8.18% during 2021-2028.
 

Rising cases of hospital acquired infections among patients coupled with increasing prevalence of sepsis are the primary factors driving the global sepsis diagnostics market growth. In addition, government initiatives for research activities relating to sepsis are enhancing the market outlook.
 

Request sample copy of this Report: https://www.marketstudyreport.com/request-a-sample/3754652/
 

However, high costs of the instruments along with reimbursement issues are restraining the market growth, cites the study.
 

Based on technology, global sepsis diagnostics industry is segmented into microbiology, molecular diagnostics, immunoassay, and other technologies. On the basis of diagnostics method, the industry is divided into automated diagnostics and conventional diagnostics.
 

Speaking of product range, the marketplace is categorized into blood culture media, instruments and assay kits & reagents among others. In terms of pathogens, the industry space is classified into fungal sepsis, gram-positive & gram-negative bacterial sepsis and other pathogens. Moving on to testing type, the industry is fragmented into point-of-care testing and laboratory testing.
 

Considering the geographical analysis, the industry is fragmented into North America, Latin America, Middle East & Africa, Europe, and Asia-Pacific regions. The study encompasses a detailed analysis of the current and predicted sizes of these markets to help stakeholders identify the top investment areas for the upcoming years.
 

As stated in the report Asia-Pacific market will likely showcase strong growth trends over the forecast period, owing to rapid economic development and innovations in medical systems in emerging economies like India and China. Furthermore, the demand for sepsis diagnostics is likely to increase due to high mortality rate linked with sepsis disease. Moreover, growing awareness among people about the diagnosis and treatment of the condition is positively swaying the industry dynamics in the region.
 

Leading players influencing the worldwide sepsis diagnostics industry trends are Thermo Fisher Scientific Inc., T2 Biosystems Inc., Response Biomedical Corporation, Luminex Corporation, Immunexpress Inc., F. Hoffmann-La Roche AG, EKF Diagnostics, Danaher Corporation, CytoSorbents Corporation, Bruker Corporation, Becton Dickinson and Company, Abbott Laboratories, and BioMérieux SA.